Searching for "Xie Fangmin"
Found 13 result(s)
Showing 3 article(s). 10 more available to premium subscribers.
Guangdong-based Jianke Pharmaceutical, operator of B2C pharmaceutical e-commerce site Jianke.com, has announced the acquisition of Wuhan-based Xiong Chu Hospital. Read More
Guangdong-based Jianke Pharmaceutical, operator of B2C pharmaceutical e-tailer Jianke.com, has completed USD 50 mln in Series A+ funding, announced Jianke CEO Xie Fangmin. Read More
Xie Fangmin, CEO of Guangdong-based Jianke Pharmaceutical, recently revealed that the Jianke.com online pharmacy operator has completed USD 100 mln Series A funding from investment firm Crescent Point and will focus on mobile medicine in 2016. Read More